Bronopol Market Size, Share, Demand, Report, Forecast 2024-2032

1. Global Poultry Vaccines Market Research and Forecast Report 2024-2032 Format: PDF+EXCEL © 2023 IMARC All Rights Reserved

2. About IMARC Group • International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. • IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. • IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Highlight and Description • According to the latest report by IMARC Group, titled "Poultry Vaccines Market:Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032,“ The global poultry vaccines market size reached US$ 1.9 Billion in 2023. • Poultry Vaccines (POM), also known as polyacetal, is a semi-crystalline engineering thermoplastic with high tensile strength. It is used as an alternative to metals due to its low friction and wear characteristics as well as an excellent balance of mechanical and chemical properties. It offers high resistance to heat, abrasion, water, and chemical compounds, which makes it suitable for producing high-precision parts of machines. Apart from this, it offers several advantages, such as low smoke emission, moisture absorption and high gloss surfaces. • Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.6% during 2024-2032. • Request for a PDF sample of this report: • https://www.imarcgroup.com/poultry-vaccines-market/requestsample

4. Report Description • Global Poultry Vaccines Market Trends: • The market is primarily driven by the rising awareness regarding animal vaccination among veterinary practitioners and increasing prevalence of zoonotic diseases. Diseases, such as bird flu or avian influenza, are also known to infect humans and animals. Besides this, the escalating demand for animal health diagnostics also represents a major factor contributing to the market growth. In addition, the growing consumption of meat and poultry-related food products is facilitating extensive expenditure on poultry healthcare. Along with this, governmental bodies across the globe are taking initiatives to educate people regarding the benefits of poultry vaccines, thus accelerating the product adoption rate. • Furthermore, growing research and development (R&D) activities to develop advanced technologies to manufacture effective vaccines are creating a positive outlook for the market. For instance, there has been an introduction of live, non-replicating recombinant antigens, nucleic acid-mediated, and live-gene detected vaccines. • View Report, TOC, Figures and Tables: https://www.imarcgroup.com/poultry-vaccines-market

5. Report Segmentation • Breakup by Disease: • Infectious Bronchitis • Avian Influenza • Newcastle Disease • Marek's Disease • Others • Breakup by Product: • Recombinant Vaccine • Live Attenuated Vaccine • Inactivated Vaccine • Subunit Vaccine • Others

6. Report Segmentation Breakup by Dosage Form: • Liquid Vaccine • Freeze Dried Vaccine Breakup by Application: • Breeder • Broiler • Layer Breakup by End User: • Veterinary Hospitals • Poultry Firm • Poultry Vaccination Center

7. Report Segmentation Breakup by Region: • North America (United States, Canada) • Asia Pacific (China, Japan, India, Australia, Indonesia, South Korea, Others) • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others) • Latin America (Brazil, Mexico, Others) • Middle East and Africa

8. Competitive Landscape • AniCon Labor GmbH (SAN Group) Biovac Ltd. • Boehringer Ingelheim International GmbH • CevaSantéAnimale • Elanco • Hester Biosciences Limited • Merck & Co. Inc. • Phibro Animal Health Corporation • Venkys India • Zoetis Inc.

9. Key Questions Answered in the Report What was the size of the global poultry vaccines market in 2023? What is the expected growth rate of the global poultry vaccines market during 2024-2032? What has been the impact of COVID-19 on the global poultry vaccines market? What are the key factors driving the global poultry vaccines market? What is the breakup of the global poultry vaccines market based on the disease? What is the breakup of the global poultry vaccines market based on the product?

10. Key Questions Answered in the Report What is the breakup of the global poultry vaccines market based on the dosage form? What is the breakup of the global poultry vaccines market based on the application? What are the key regions in the global poultry vaccines market? Who are the key players/companies in the global poultry vaccines market?

11. 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Poultry Vaccines Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Disease 6.1 Infectious Bronchitis 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Avian Influenza 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Newcastle Disease 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Marek's Disease 6.4.1 Market Trends Table of Contents

12. 6.4.2 Market Forecast 6.5 Others 6.5.1 Market Trends 6.5.2 Market Forecast 7 Market Breakup by Product 7.1 Recombinant Vaccine 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Live Attenuated Vaccine 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Inactivated Vaccine 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Subunit Vaccine 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Others 7.5.1 Market Trends 7.5.2 Market Forecast 8 Market Breakup by Dosage Form 8.1 Liquid Vaccine 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Freeze Dried Vaccine 8.2.1 Market Trends 8.2.2 Market Forecast 9 Market Breakup by Application 9.1 Breeder 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Broiler Table of Contents

13. 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Layer 9.3.1 Market Trends 9.3.2 Market Forecast 10 Market Breakup by End User 10.1 Veterinary Hospitals 10.1.1 Market Trends 10.1.2 Market Forecast 10.2 Poultry Firm 10.2.1 Market Trends 10.2.2 Market Forecast 10.3 Poultry Vaccination Center 10.3.1 Market Trends 10.3.2 Market Forecast 11 Market Breakup by Region 11.1 North America 11.1.1 United States 11.1.1.1 Market Trends 11.1.1.2 Market Forecast 11.1.2 Canada 11.1.2.1 Market Trends 11.1.2.2 Market Forecast 11.2 Asia-Pacific 11.2.1 China 11.2.1.1 Market Trends 11.2.1.2 Market Forecast 11.2.2 Japan 11.2.2.1 Market Trends 11.2.2.2 Market Forecast 11.2.3 India 11.2.3.1 Market Trends Table of Contents

14. 11.2.3.2 Market Forecast 11.2.4 South Korea 11.2.4.1 Market Trends 11.2.4.2 Market Forecast 11.2.5 Australia 11.2.5.1 Market Trends 11.2.5.2 Market Forecast 11.2.6 Indonesia 11.2.6.1 Market Trends 11.2.6.2 Market Forecast 11.2.7 Others 11.2.7.1 Market Trends 11.2.7.2 Market Forecast 11.3 Europe 11.3.1 Germany 11.3.1.1 Market Trends 11.3.1.2 Market Forecast 11.3.2 France 11.3.2.1 Market Trends 11.3.2.2 Market Forecast 11.3.3 United Kingdom 11.3.3.1 Market Trends 11.3.3.2 Market Forecast 11.3.4 Italy 11.3.4.1 Market Trends 11.3.4.2 Market Forecast 11.3.5 Spain 11.3.5.1 Market Trends 11.3.5.2 Market Forecast 11.3.6 Russia 11.3.6.1 Market Trends 11.3.6.2 Market Forecast Table of Contents

15. 11.3.7 Others 11.3.7.1 Market Trends 11.3.7.2 Market Forecast 11.4 Latin America 11.4.1 Brazil 11.4.1.1 Market Trends 11.4.1.2 Market Forecast 11.4.2 Mexico 11.4.2.1 Market Trends 11.4.2.2 Market Forecast 11.4.3 Others 11.4.3.1 Market Trends 11.4.3.2 Market Forecast 11.5 Middle East and Africa 11.5.1 Market Trends 11.5.2 Market Breakup by Country 11.5.3 Market Forecast 12 SWOT Analysis 12.1 Overview 12.2 Strengths 12.3 Weaknesses 12.4 Opportunities 12.5 Threats 13 Value Chain Analysis 14 Porters Five Forces Analysis 14.1 Overview 14.2 Bargaining Power of Buyers 14.3 Bargaining Power of Suppliers 14.4 Degree of Competition 14.5 Threat of New Entrants 14.6 Threat of Substitutes Table of Contents

16. 15 Price Analysis 16 Competitive Landscape 16.1 Market Structure 16.2 Key Players 16.3 Profiles of Key Players 16.3.1 AniCon Labor GmbH (SAN Group) 16.3.1.1 Company Overview 16.3.1.2 Product Portfolio 16.3.2 Biovac Ltd. 16.3.2.1 Company Overview 16.3.2.2 Product Portfolio 16.3.3 Boehringer Ingelheim International GmbH 16.3.3.1 Company Overview 16.3.3.2 Product Portfolio 16.3.4 CevaSantéAnimale 16.3.4.1 Company Overview 16.3.4.2 Product Portfolio 16.3.5 Elanco 16.3.5.1 Company Overview 16.3.5.2 Product Portfolio 16.3.5.3 Financials 16.3.6 Hester Biosciences Limited 16.3.6.1 Company Overview 16.3.6.2 Product Portfolio 16.3.6.3 Financials 16.3.7 Merck & Co. Inc. 16.3.7.1 Company Overview 16.3.7.2 Product Portfolio 16.3.7.3 Financials 16.3.7.4 SWOT Analysis 16.3.8 Phibro Animal Health Corporation 16.3.8.1 Company Overview Table of Contents

17. 16.3.8.2 Product Portfolio 16.3.8.3 Financials 16.3.8.4 SWOT Analysis 16.3.9 Venkys India 16.3.9.1 Company Overview 16.3.9.2 Product Portfolio 16.3.10 Zoetis Inc. 16.3.10.1 Company Overview 16.3.10.2 Product Portfolio 16.3.10.3 Financials 16.3.10.4 SWOT Analysis For more information, visit: https://www.imarcgroup.com/poultry-vaccines-market/toc Table of Contents

18. Partial List of Clients

19. Partial List of Clients

20. Disclaimer © 2024 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

21. Contact Us Visit us at : https://www.imarcgroup.com • +1-631-791-1145 • sales@imarcgroup.com Stay With Us: